Author:
Paul Mical,Schlesinger Agata,Grozinsky-Glasberg Simona,Soares-Weiser Karla,Leibovici Leonard
Reference145 articles.
1. Cost-effectiveness of cefepime + netilmicin or ceftazidime + amikacin or meropenem monotherapy in febrile neutropenic children with malignancy in Turkey;Agaoglu;Journal of Chemotherapy,2001
2. Early hospital discharge versus continued hospitalization in febrile pediatric cancer patients with prolonged neutropenia: A randomized, prospective study;Ahmed;Pediatric Blood Cancer,2007
3. Outpatient single dose ceftriaxone and amikacin vs. imipenem/cilastatin monotherapy in the empiric treatment of pediatric patients with high risk fever aneutropenia. A randomized, prospective clinical trial.;N. Ahmed-El,2004
4. Outpatient Single Dose Ceftriaxone and Amikacin vs. Imipenem/cilastatin Monotherapy in the Empiric Treatment of Pediatric Patients with High Risk Fever and Neutropenia. A Randomized, Prospective Clinical Trial.;Nabil Ahmed-El,2003
5. Comparison of meropenem with amikacin plus ceftazidime in the empirical treatment of febrile neutropenia: a prospective randomised multicentre trial in patients without previous prophylactic antibiotics. Meropenem Study Group of Turkey;Akova;International Journal of Antimicrobial Agents,1999
Cited by
43 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献